Inducible expression of the alpha2-macroglobulin signaling receptor in response to antigenic stimulation: a study of second messenger generation.
Thioglycollate (TG)-elicited murine, peritoneal macrophages express two receptors for activated forms of the proteinase inhibitor alpha2-macroglobulin (alpha2M*)--namely, the low density lipoprotein receptor-related protein (LRP) and the alpha2M signaling receptor (alpha2MSR). We now report that resident peritoneal macrophages express only 400+/-50 alpha2MSR receptors/cell compared to 5000+/-500 receptor/TG-elicited macrophage. By contrast, LRP expression is only 2-2.5-fold greater on elicited cells. The low level of alpha2MSR expression by resident cells is insufficient to trigger signal transduction in contrast to TG-elicited cells which when exposed to alpha2M* demonstrate a rapid rise in inositol 1,4,5-trisphosphate and a concomitant increase in cytosolic free Ca2+. We then studied a variety of preparations injected subcutaneously for their ability to upregulate alpha2MSR. Macroaggregated bovine serum albumin (macroBSA) injection upregulated alpha2MSR and triggered signaling responses by splenic macrophages. Nonaggregated BSA injection alone or in the presence of alum, by contrast, did not alter alpha2MSR expression. Recombivax (hepatitis B antigen adsorbed to alum) injection also upregulated alpha2MSR on splenic macrophages while the alum carrier had no effect. We conclude that macrophage alpha2M* receptors are inducible and their expression may be regulated, in part, by potential antigens.
Bhattacharjee
G
G
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Misra
U K
UK
Gawdi
G
G
Cianciolo
G
G
Pizzo
S V
SV
D000276:Adjuvants, Immunologic; D000418:Albumins / Q000276:immunology; D000534:Alum Compounds / Q000494:pharmacology; D000818:Animals; D020013:Calcium Signaling / Q000187:drug effects; D002417:Cattle; D005786:Gene Expression Regulation / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000276:immunology; D015544:Inositol 1,4,5-Trisphosphate / Q000502:physiology; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000096:biosynthesis* / Q000235:genetics; D008264:Macrophages / Q000276:immunology / Q000378:metabolism*; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D010538:Peritonitis / Q000139:chemically induced / Q000276:immunology; D015290:Second Messenger Systems / Q000502:physiology*; D012710:Serum Albumin, Bovine / Q000276:immunology; D013047:Specific Pathogen-Free Organisms; D013154:Spleen / Q000166:cytology; D013864:Thioglycolates / Q000633:toxicity; D014614:Vaccines, Synthetic / Q000276:immunology; D000511:alpha-Macroglobulins / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D000418:Albumins; D000534:Alum Compounds; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D026503:Low Density Lipoprotein Receptor-Related Protein-1; C075655:Recombivax HB; D013864:Thioglycolates; D014614:Vaccines, Synthetic; D000511:alpha-Macroglobulins; D012710:Serum Albumin, Bovine; C041524:aluminum sulfate; C075321:macro aggregates of albumin; D015544:Inositol 1,4,5-Trisphosphate